| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.6 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.023 | 0.7 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |